Effect of Cashew consumption on lipid profile in diabetic patients

Effect of Cashew consumption on lipid profile, Apo B, Apo A-I, hs-CRP and Paraoxonase-1 in patients with type 2 diabetes.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138812252709N5

Enrollment

Registered

2010-03-16

Start date

2010-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes, Diabetic dyslipidemia. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Intervention: Cashew Consumption (10% of daily total calorie intake), 1 time/day, for 2 month. Intervention 2: Control: No intervention for this group.

Treatment - Other

Intervention: Cashew Consumption (10% of daily total calorie intake), 1 time/day, for 2 month

Control: No intervention for this group

Eligibility

Sex/Gender

All

Age

35 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Being volunteer or willingness to attend, age 35-70 years old, confirmed type 2 diabetes for at least 1 year (FPG = 126 mg/dl or 2hPG = 200 mg/dl), BMI = 35 kg/m2, TG 2 times/wk at least 2 months prior to the study, Changing medication dosage or physical activity level 2 months before or during the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Low Density Lipoprotein (LDL-C). Timepoint: 8 weeks. Method of measurement: Laboratory kit.;Total Cholesterol (TC). Timepoint: 8 weeks. Method of measurement: Friedewald equation.;Triglyceride (TG). Timepoint: 8 weeks. Method of measurement: Laboratory kit.;High Density Lipoprotein (HDL-C). Timepoint: 8 weeks. Method of measurement: Laboratory kit.;TC/HDL-C ratio. Timepoint: 8 weeks. Method of measurement: calculation.;LDL-C/HDL-C ratio. Timepoint: 8 weeks. Method of measurement: calculation.;Apo A-I. Timepoint: 8 weeks. Method of measurement: immunoturbidimetry.;Apo B-100. Timepoint: 8 weeks. Method of measurement: immunoturbidimetry.;Paraoxonase-1. Timepoint: 8 weeks. Method of measurement: spectrophotometry.;Fasting Blood Sugar (FBS). Timepoint: 8 weeks. Method of measurement: Enzymatic.;Fasting Insulin. Timepoint: 8 weeks. Method of measurement: Enzymatic.;Total Antioxidant Capacity (TAC). Timepoint: 8 weeks. Method of measurement: Ferric reducing ability of plasma (FRAP).;High sensitivity C-reactive protein (hs-CRP). Timepoint: 8 weeks. Method of measurement: immunoturbidimetry.;Blood pressure. Timepoint: 8 weeks. Method of measurement: sphygmomanometer.	—

Measure

Time frame

Low Density Lipoprotein (LDL-C). Timepoint: 8 weeks. Method of measurement: Laboratory kit.;Total Cholesterol (TC). Timepoint: 8 weeks. Method of measurement: Friedewald equation.;Triglyceride (TG). Timepoint: 8 weeks. Method of measurement: Laboratory kit.;High Density Lipoprotein (HDL-C). Timepoint: 8 weeks. Method of measurement: Laboratory kit.;TC/HDL-C ratio. Timepoint: 8 weeks. Method of measurement: calculation.;LDL-C/HDL-C ratio. Timepoint: 8 weeks. Method of measurement: calculation.;Apo A-I. Timepoint: 8 weeks. Method of measurement: immunoturbidimetry.;Apo B-100. Timepoint: 8 weeks. Method of measurement: immunoturbidimetry.;Paraoxonase-1. Timepoint: 8 weeks. Method of measurement: spectrophotometry.;Fasting Blood Sugar (FBS). Timepoint: 8 weeks. Method of measurement: Enzymatic.;Fasting Insulin. Timepoint: 8 weeks. Method of measurement: Enzymatic.;Total Antioxidant Capacity (TAC). Timepoint: 8 weeks. Method of measurement: Ferric reducing ability of plasma (FRAP).;High sensitivity C-reactive protein (hs-CRP). Timepoint: 8 weeks. Method of measurement: immunoturbidimetry.;Blood pressure. Timepoint: 8 weeks. Method of measurement: sphygmomanometer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Farzad Shidfar

Iran University of Medical Sciences

shidfar44@iums.ac.ir+98 21 8860 2218

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026